CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Merck and Co Inc   (MRK)
Other Ticker:  
 

Cumulative Merck And Co Inc 's Quick Ratio for Trailing Twelve Months Period

MRK's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

MRK Quick Ratio for Trailing Twelve Months Period

 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Current Liabilities Growth 6 % 0.42 % 0.98 % 3.65 % 1.54 %
Y / Y Cash & cash equivalent Growth -46.23 % -22 % -37.03 % 16.34 % 62.94 %
Quick Ratio for Trailing Twelve Months Period 0.34 0.41 0.44 0.48 0.47
Total Ranking # # 2159 # 2231 # 2354 # 2815
Seq. Current Liabilities Growth 11.26 % -1.28 % 1.14 % -4.57 % 5.4 %
Seq. Cash & cash equivalent Growth -19.15 % 37.55 % -38.6 % -21.26 % 17.28 %

MRK Segments >> Back to MRK Financial Strength Comparisons >> Compare MRK Quick Ratio to its Competitors

Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Due to increase in Current Liabilities in the IV. Quarter to $25,694 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 0.34 below Merck And Co Inc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 267 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Merck And Co Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about MRK
Quick Ratio MRK in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 268
Sector # 533
S&P 500 # 1861


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
1.26 0.71 0.32
(Dec. 30, 2009)   (Jun 30 2021)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Cti Biopharma Corp   0.93 
Heron Therapeutics Inc   0.93 
Rockwell Medical inc   0.92 
Vaccinex Inc   0.92 
Transcode Therapeutics Inc   0.91 
Ascendis Pharma A  0.90 
Novabay Pharmaceuticals Inc   0.90 
Kamada Ltd   0.90 
Evelo Biosciences Inc   0.88 
Xencor Inc  0.87 
Cns Pharmaceuticals Inc   0.87 
Kintara Therapeutics Inc   0.87 
Sellas Life Sciences Group Inc   0.86 
Avalo Therapeutics inc   0.85 
Palatin Technologies Inc   0.85 
Phibro Animal Health Corporation  0.85 
Effector Therapeutics Inc   0.84 
Avenue Therapeutics Inc   0.83 
Biora Therapeutics Inc   0.82 
Therapeuticsmd Inc   0.81 
Morphosys Ag  0.81 
Entrada Therapeutics Inc   0.79 
180 Life Sciences Corp  0.79 
Sonoma Pharmaceuticals Inc   0.79 
Dar Bioscience Inc   0.77 
Elite Pharmaceuticals Inc   0.77 
Neurosense Therapeutics Ltd   0.76 
Sonnet Biotherapeutics Holdings Inc   0.76 
Medicure Inc   0.74 
Intercure Ltd   0.74 




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com